Given that increased TFE3 in HNSCC is related to the HIF pathway, TFE3 expression increased in a time-dependent manner under hypoxia [29], which was inhibited when treated with a hypoxia inhibitor [30]. The gene discussed is TFE3; the disease is head and neck squamous cell carcinoma.